A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context
Summary: Background: Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen that causes severe hemorrhagic fever in humans, but no FDA-approved specific antivirals or vaccines are available to treat or prevent SFTS. Methods: The plasmids construction and transf...
| मुख्य लेखकों: | , , , , , , , , , , , , |
|---|---|
| स्वरूप: | लेख |
| भाषा: | English |
| प्रकाशित: |
Elsevier
2024-01-01
|
| श्रृंखला: | EBioMedicine |
| विषय: | |
| ऑनलाइन पहुंच: | http://www.sciencedirect.com/science/article/pii/S2352396423005108 |
| _version_ | 1827390387763806208 |
|---|---|
| author | Huan Xu Xiaoqin Jian Yuxi Wen Mengwei Xu Runming Jin Xiaoyan Wu Fen Zhou Junyuan Cao Gengfu Xiao Ke Peng Yuanchao Xie Hongbo Chen Leike Zhang |
| author_facet | Huan Xu Xiaoqin Jian Yuxi Wen Mengwei Xu Runming Jin Xiaoyan Wu Fen Zhou Junyuan Cao Gengfu Xiao Ke Peng Yuanchao Xie Hongbo Chen Leike Zhang |
| author_sort | Huan Xu |
| collection | DOAJ |
| description | Summary: Background: Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen that causes severe hemorrhagic fever in humans, but no FDA-approved specific antivirals or vaccines are available to treat or prevent SFTS. Methods: The plasmids construction and transfection were performed to generate the recombinant SFTSV harboring the nanoluciferase gene (SFTSV-Nluc). Immunostaining plaque assay was performed to measure viral titers, and DNA electrophoresis and Sanger sequencing were performed to evaluate the genetic stability. Luciferase assay and quantitative RT-PCR were performed to evaluate the efficacy of antivirals in vitro. Bioluminescence imaging, titration of virus from excised organs, hematology, and histopathology and immunohistochemistry were performed to evaluate the efficacy of antivirals in vivo. Findings: SFTSV-Nluc exhibited high genetic stability and replication kinetics similar to those of wild-type virus (SFTSVwt), then a rapid high-throughput screening system for identifying inhibitors to treat SFTS was developed, and a nucleoside analog, 4-FlU, was identified to effectively inhibit SFTSV in vitro. SFTSV-Nluc mimicked the replication characteristics and localization of SFTSVwt in counterpart model mice. Bioluminescence imaging of SFTSV-Nluc allowed real-time visualization and quantification of SFTSV replication in the mice. 4-FlU was demonstrated to inhibit the replication of SFTSV with more efficiency than T-705 and without obvious adverse effect in vivo. Interpretation: The high-throughput screening system based on SFTSV-Nluc for use in vitro and in vivo revealed that a safe and effective antiviral nucleoside analog, 4-FlU, may be a basis for the strategic treatment of SFTSV and other bunyavirus infections, paving the way for the discovery of antivirals. Funding: This work was supported by grants from the National Key Research and Development Plan of China (2021YFC2300700 to L. Zhang, 2022YFC2303300 to L. Zhang), Strategic Priority Research Program of Chinese Academy of Sciences (XDB0490000 to L. Zhang), National Natural Science Foundation of China (31970165 to L. Zhang, U22A20379 to G. Xiao), the Science and Technology Commission of Shanghai Municipality (21S11903100 to Y. Xie), Hubei Natural Science Foundation for Distinguished Young Scholars (2022CFA099 to L. Zhang). |
| first_indexed | 2024-03-08T16:51:00Z |
| format | Article |
| id | doaj.art-5d74fa6be68a495196b51a43c2d70518 |
| institution | Directory Open Access Journal |
| issn | 2352-3964 |
| language | English |
| last_indexed | 2024-03-08T16:51:00Z |
| publishDate | 2024-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | EBioMedicine |
| spelling | doaj.art-5d74fa6be68a495196b51a43c2d705182024-01-05T04:24:58ZengElsevierEBioMedicine2352-39642024-01-0199104944A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in contextHuan Xu0Xiaoqin Jian1Yuxi Wen2Mengwei Xu3Runming Jin4Xiaoyan Wu5Fen Zhou6Junyuan Cao7Gengfu Xiao8Ke Peng9Yuanchao Xie10Hongbo Chen11Leike Zhang12Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaState Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China; University of Chinese Academy of Sciences, Beijing, ChinaDepartment of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaState Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, ChinaDepartment of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaDepartment of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaDepartment of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, ChinaHubei Jiangxia Laboratory, Wuhan, 430200, ChinaState Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China; University of Chinese Academy of Sciences, Beijing, ChinaState Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China; University of Chinese Academy of Sciences, Beijing, China; Corresponding author. State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China.Lingang Laboratory, Shanghai, 200031, China; Corresponding author.Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China; Corresponding author.State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China; University of Chinese Academy of Sciences, Beijing, China; Hubei Jiangxia Laboratory, Wuhan, 430200, China; Corresponding author. State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, Hubei, 430071, China.Summary: Background: Severe fever with thrombocytopenia syndrome virus (SFTSV) is an emerging tick-borne pathogen that causes severe hemorrhagic fever in humans, but no FDA-approved specific antivirals or vaccines are available to treat or prevent SFTS. Methods: The plasmids construction and transfection were performed to generate the recombinant SFTSV harboring the nanoluciferase gene (SFTSV-Nluc). Immunostaining plaque assay was performed to measure viral titers, and DNA electrophoresis and Sanger sequencing were performed to evaluate the genetic stability. Luciferase assay and quantitative RT-PCR were performed to evaluate the efficacy of antivirals in vitro. Bioluminescence imaging, titration of virus from excised organs, hematology, and histopathology and immunohistochemistry were performed to evaluate the efficacy of antivirals in vivo. Findings: SFTSV-Nluc exhibited high genetic stability and replication kinetics similar to those of wild-type virus (SFTSVwt), then a rapid high-throughput screening system for identifying inhibitors to treat SFTS was developed, and a nucleoside analog, 4-FlU, was identified to effectively inhibit SFTSV in vitro. SFTSV-Nluc mimicked the replication characteristics and localization of SFTSVwt in counterpart model mice. Bioluminescence imaging of SFTSV-Nluc allowed real-time visualization and quantification of SFTSV replication in the mice. 4-FlU was demonstrated to inhibit the replication of SFTSV with more efficiency than T-705 and without obvious adverse effect in vivo. Interpretation: The high-throughput screening system based on SFTSV-Nluc for use in vitro and in vivo revealed that a safe and effective antiviral nucleoside analog, 4-FlU, may be a basis for the strategic treatment of SFTSV and other bunyavirus infections, paving the way for the discovery of antivirals. Funding: This work was supported by grants from the National Key Research and Development Plan of China (2021YFC2300700 to L. Zhang, 2022YFC2303300 to L. Zhang), Strategic Priority Research Program of Chinese Academy of Sciences (XDB0490000 to L. Zhang), National Natural Science Foundation of China (31970165 to L. Zhang, U22A20379 to G. Xiao), the Science and Technology Commission of Shanghai Municipality (21S11903100 to Y. Xie), Hubei Natural Science Foundation for Distinguished Young Scholars (2022CFA099 to L. Zhang).http://www.sciencedirect.com/science/article/pii/S2352396423005108Severe fever with thrombocytopenia syndrome virusNanoluciferase reporter geneHigh-throughput drug screeningIn vivo bioluminescence imaging4′-fluorouridine |
| spellingShingle | Huan Xu Xiaoqin Jian Yuxi Wen Mengwei Xu Runming Jin Xiaoyan Wu Fen Zhou Junyuan Cao Gengfu Xiao Ke Peng Yuanchao Xie Hongbo Chen Leike Zhang A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context EBioMedicine Severe fever with thrombocytopenia syndrome virus Nanoluciferase reporter gene High-throughput drug screening In vivo bioluminescence imaging 4′-fluorouridine |
| title | A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context |
| title_full | A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context |
| title_fullStr | A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context |
| title_full_unstemmed | A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context |
| title_short | A nanoluciferase SFTSV for rapid screening antivirals and real-time visualization of virus infection in miceResearch in context |
| title_sort | nanoluciferase sftsv for rapid screening antivirals and real time visualization of virus infection in miceresearch in context |
| topic | Severe fever with thrombocytopenia syndrome virus Nanoluciferase reporter gene High-throughput drug screening In vivo bioluminescence imaging 4′-fluorouridine |
| url | http://www.sciencedirect.com/science/article/pii/S2352396423005108 |
| work_keys_str_mv | AT huanxu ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT xiaoqinjian ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT yuxiwen ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT mengweixu ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT runmingjin ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT xiaoyanwu ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT fenzhou ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT junyuancao ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT gengfuxiao ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT kepeng ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT yuanchaoxie ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT hongbochen ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT leikezhang ananoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT huanxu nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT xiaoqinjian nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT yuxiwen nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT mengweixu nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT runmingjin nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT xiaoyanwu nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT fenzhou nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT junyuancao nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT gengfuxiao nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT kepeng nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT yuanchaoxie nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT hongbochen nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext AT leikezhang nanoluciferasesftsvforrapidscreeningantiviralsandrealtimevisualizationofvirusinfectioninmiceresearchincontext |